↓ Skip to main content

Resensitization to Crizotinib by the Lorlatinib ALK Resistance Mutation L1198F

Overview of attention for article published in New England Journal of Medicine, December 2015
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (98th percentile)
  • Good Attention Score compared to outputs of the same age and source (74th percentile)

Mentioned by

news
9 news outlets
twitter
162 X users
facebook
6 Facebook pages

Citations

dimensions_citation
434 Dimensions

Readers on

mendeley
372 Mendeley